562 related articles for article (PubMed ID: 18471139)
21. 5-HT receptors and visceral hypersensitivity - 2B or not 2B, that is the question?
Grundy D
Neurogastroenterol Motil; 2006 May; 18(5):339-42. PubMed ID: 16629859
[No Abstract] [Full Text] [Related]
22. The importance of 5-hydroxytryptamine receptors in the gut.
Read NW; Gwee KA
Pharmacol Ther; 1994; 62(1-2):159-73. PubMed ID: 7991641
[TBL] [Abstract][Full Text] [Related]
23. Role of serotonin1A and serotonin2 receptors in the central regulation of the cardiovascular system.
McCall RB; Clement ME
Pharmacol Rev; 1994 Sep; 46(3):231-43. PubMed ID: 7831380
[No Abstract] [Full Text] [Related]
24. [Pharmacology of 5-hydroxytryptamine receptors].
Fontaine J
J Pharm Belg; 1996; 51(3):141-51. PubMed ID: 8778347
[No Abstract] [Full Text] [Related]
25. Serotonergic-postsynaptic receptors modulate gripping-induced immobility episodes in male taiep rats.
Eguibar JR; Cortés MC; Ita ML
Synapse; 2009 Sep; 63(9):737-44. PubMed ID: 19484723
[TBL] [Abstract][Full Text] [Related]
26. [Aggregation and 3H-serotonin release from thrombocytes stimulated by serotonin in patients with migraine].
Pukhal'skaia TG; Kolosova OA; Men'shikov MIu
Biull Eksp Biol Med; 1998 Aug; 126(8):156-9. PubMed ID: 9777225
[No Abstract] [Full Text] [Related]
27. The serotonin signaling system: from basic understanding to drug development for functional GI disorders.
Gershon MD; Tack J
Gastroenterology; 2007 Jan; 132(1):397-414. PubMed ID: 17241888
[TBL] [Abstract][Full Text] [Related]
28. Problems of drug selectivity and dose--pharmacology.
Ramage A
J Physiol; 2005 Dec; 569(Pt 2):711; author reply 712. PubMed ID: 16322062
[No Abstract] [Full Text] [Related]
29. Serotonin and blood pressure regulation.
Watts SW; Morrison SF; Davis RP; Barman SM
Pharmacol Rev; 2012 Apr; 64(2):359-88. PubMed ID: 22407614
[TBL] [Abstract][Full Text] [Related]
30. [Irritable bowel syndrome: pathophysiology and (future) treatment options].
de Schryver AM; Samsom M
Ned Tijdschr Geneeskd; 2002 Jan; 146(1):12-7. PubMed ID: 11802330
[TBL] [Abstract][Full Text] [Related]
31. Serotonin1C,2 receptors and endurance performance. An illustration of the limits of pharmacological tools in exercise science.
Chaouloff F
Int J Sports Med; 1994 Aug; 15(6):339-11. PubMed ID: 7822075
[No Abstract] [Full Text] [Related]
32. Serotonergic thrombocytopathy and its effects on platelets during orthopaedic surgery.
Childs SG
Orthop Nurs; 2008; 27(1):42-7; quiz 48-9. PubMed ID: 18300689
[TBL] [Abstract][Full Text] [Related]
33. Actions of novel agonists, antagonists and antipsychotic agents at recombinant rat 5-HT6 receptors: a comparative study of coupling to G alpha s.
Dupuis DS; Mannoury la Cour C; Chaput C; Verrièle L; Lavielle G; Millan MJ
Eur J Pharmacol; 2008 Jul; 588(2-3):170-7. PubMed ID: 18511034
[TBL] [Abstract][Full Text] [Related]
34. Understanding behavior: serotonin syndrome.
Crowell-Davis SL; Poggiagliolmi S
Compend Contin Educ Vet; 2008 Sep; 30(9):490-3. PubMed ID: 18951363
[No Abstract] [Full Text] [Related]
35. Irritable bowel syndrome: new horizons in pathophysiology and treatment.
Bose M; Farthing MJ
Br J Surg; 2001 Nov; 88(11):1425-6. PubMed ID: 11683735
[No Abstract] [Full Text] [Related]
36. [Biochemical mechanisms in the physiopathology of migraine].
Manivet P; Soliman HR; Callebert J; Laplanche JL; Launay JM
Pathol Biol (Paris); 2000 Sep; 48(7):630-41. PubMed ID: 11072641
[TBL] [Abstract][Full Text] [Related]
37. Review article: The role of serotonergic agents in the treatment of patients with primary chronic constipation.
Cash BD; Chey WD
Aliment Pharmacol Ther; 2005 Dec; 22(11-12):1047-60. PubMed ID: 16305718
[TBL] [Abstract][Full Text] [Related]
38. The role of the endocannabinoid system in the pathophysiology and treatment of irritable bowel syndrome.
Storr MA; Yüce B; Andrews CN; Sharkey KA
Neurogastroenterol Motil; 2008 Aug; 20(8):857-68. PubMed ID: 18710476
[TBL] [Abstract][Full Text] [Related]
39. Serotonergic and non-serotonergic targets in the pharmacotherapy of visceral hypersensitivity.
Bueno L; de Ponti F; Fried M; Kullak-Ublick GA; Kwiatek MA; Pohl D; Quigley EM; Tack J; Talley NJ
Neurogastroenterol Motil; 2007 Jan; 19(1 Suppl):89-119. PubMed ID: 17280587
[TBL] [Abstract][Full Text] [Related]
40. Novel therapeutic targets for enteric nervous system disorders.
De Giorgio R; Barbara G; Furness JB; Tonini M
Trends Pharmacol Sci; 2007 Sep; 28(9):473-81. PubMed ID: 17764756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
